Efficacy of Once-Yearly Intravenous Zoledronic Acid for Osteopenia / 대한골다공증학회지
Journal of Korean Society of Osteoporosis
; : 114-118, 2013.
Article
in Korean
| WPRIM (Western Pacific)
| ID: wpr-760814
Responsible library:
WPRO
ABSTRACT
OBJECTIVES:
To assess the clinical efficacy of once-yearly treatment with Zoledronic acid in patients with osteopenia. MATERIALS ANDMETHODS:
From June 2009 to November 2011, patients diagnosed with osteopenia were applied to fracture risk assessment tool (FRAX). Among them, 40 patients who showed high possibility of osteoporotic fracture were selected and treated with intravenous zoledronic acid once-yearly. At the baseline and after one year of injection of zoledronate, we measured the changes in the bone mineral density (BMD) and bone turnover markers In addition, we analyzed the side effects and thereby assessed the drug safety.
Full text:
Available
Database:
WPRIM (Western Pacific)
Main subject:
Bone Diseases, Metabolic
/
Bone Resorption
/
Bone Density
/
Osteocalcin
/
Risk Assessment
/
Osteoporotic Fractures
/
Hip
Type of study:
Etiology study
/
Risk factors
Limits:
Humans
Language:
Korean
Journal:
Journal of Korean Society of Osteoporosis
Year:
2013
Document type:
Article
